Neutral
Danaher closes $9.9B Masimo buyout
Danaher has completed its $9.9 billion acquisition of Masimo, positioning itself as a major competitor to Medtronic in the pulse oximetry market. The ...
DHR
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (15)
Neutral (22)
Bearish (1)
Latest DHR News
Neutral
Bullish
Danaher Closes $9.9B Acquisition of Masimo
Danaher has completed its $9.9 billion acquisition of Masimo, a specialty diagnostics provider known for pulse oximetry and patient monitoring solutio...
Bullish
Danaher Completes Acquisition Of Masimo to Expand Diagnostics Portfolio
Danaher has finalized its acquisition of Masimo Corporation, integrating the pulse oximetry and patient monitoring specialist into its Diagnostics seg...
Bullish
Danaher completes $10B acquisition of Masimo
Danaher has successfully completed its $10 billion acquisition of Masimo, a health monitoring technology company. This strategic move aims to strength...
Neutral
Danaher Completes Acquisition of Masimo, Expanding Acute Care Diagnostics Platform
Danaher Corporation has finalized its acquisition of Masimo Corporation, integrating Masimo's patient monitoring and pulse oximetry business into Dana...
Bullish
Danaher Corporation Completes Acquisition of Masimo Corporation on June 10, 2026
Danaher Corporation has completed its acquisition of Masimo Corporation on June 10, 2026, integrating Masimo’s medical technology into Danaher's life ...
Bullish
Danaher acquires Masimo to bolster diagnostics capabilities
Danaher (NYSE:DHR) has completed its acquisition of Masimo (NASDAQ:MASI), a specialty diagnostics provider, to expand its diagnostics portfolio. Masim...
Bullish
Danaher Completes Acquisition of Masimo Corporation
Danaher Corporation has completed its acquisition of Masimo Corporation, making Masimo a wholly-owned subsidiary within Danaher's Diagnostics segment....
Neutral
Wolfe Research Downgrades Danaher Corporation (DHR)
Wolfe Research downgraded Danaher Corporation (DHR) to Peer Perform on June 1st, citing
Neutral
Wolfe Research Downgrades Danaher Corporation (DHR)
Wolfe Research downgraded Danaher Corporation (NYSE:DHR) to Peer Perform from Outperform, citing similar growth to Thermo Fisher, which is "a little c...
Neutral
Danaher Corp. stock (US2358511028): Diagnostics and life science group after recent earnings in focu
Danaher Corp. (US2358511028) remains a focus for investors following its latest quarterly report and 2024 outlook, which showed stabilizing demand in ...
Bullish
Phenomenex Introduces Luna Omega HILIC LC Columns to Increase Sensitivity and Consistency in Polar Compound Analysis
Phenomenex Inc. has launched its new Luna Omega HILIC LC Columns, designed to improve the separation of highly polar and hydrophilic compounds. These ...
Bullish
Phenomenex Introduces Luna Omega HILIC LC Columns to Increase Sensitivity and Consistency in Polar Compound Analysis
Phenomenex Inc. has launched its new Luna Omega HILIC LC Columns, designed to improve the separation and retention of highly polar and hydrophilic com...
Neutral
Capital International Inc. CA Has $65.42 Million Position in Danaher Corporation $DHR
Capital International Inc. CA lifted its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 4.9% in the 4th quarter, according to i...
Bearish
Danaher Insiders Sold US$235m Of Shares Suggesting Hesitancy
Over the past year, Danaher Corporation (NYSE:DHR) insiders sold US$235 million worth of shares, suggesting some hesitancy among them. The largest sin...
Neutral
Pincus Capital Management LP Takes Position in Danaher Corporation $DHR
Pincus Capital Management LP purchased a new stake in shares of Danaher Corporation (NYSE:DHR – Free Report) during the fourth quarter, according to t...
Bullish
Leica Biosystems Announces Expansion of Collaboration to Scale Precision Medicine and Develop AI-Powered Diagnostics
Leica Biosystems is expanding its collaboration with AstraZeneca and Daiichi Sankyo to develop an immunohistochemistry (IHC) assay and an AI-powered i...
Neutral
What Danaher (DHR)'s New AI-Enabled SCIEX Mass Spec Platform Means For Shareholders
Danaher's SCIEX unit has launched new AI-enabled mass spectrometry platforms, enhancing its presence in data-intensive life science research. These up...
Neutral
Danaher Corp. stock (US2358511028): Wolfe Research starts coverage as shares trade lower
Wolfe Research has initiated coverage on Danaher Corp. (DHR) with a "Peer Perform" rating, as the stock traded lower on the NYSE. The initiation comes...
Neutral
DHR Assumed by Wolfe Research -- Rating Set to Peer Perform
Wolfe Research has initiated coverage on Danaher (DHR) with a "Peer Perform" rating. This follows mixed analyst sentiment, including a recent downgrad...
Research DHR on:
Ad Space